Deep Tech Startups

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.

7 investors

Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation. The platform enables biopharma companies to speed up cell therapy development, reduce manufacturing costs, and expand their pipeline of potential treatments.

7 investors

Synvivia develops chemical control technology over cell behavior to optimize the biomanufacturing of high-value biopharmaceutical products. It operates in the synthetic biology and drug discovery space.

7 investors

Transfr provides career exploration, training, and employability development programs through web, mobile, and virtual reality platforms to help learners from all backgrounds discover and prepare for in-demand jobs in high-growth industries. The company serves schools, workforce development organizations, and community programs seeking to connect learners to meaningful career pathways and upward mobility.

7 investors

Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications. The company works on novel gene network therapies for challenging diseases.

7 investors

Tzafon develops machine intelligence systems focused on multimodality, high-performance compute, and continuous learning. The company serves organizations requiring advanced AI capabilities.

7 investors

Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.

7 investors

Undermind provides AI-powered research discovery tools that help R&D teams find relevant scientific papers and research quickly. The platform serves biotech and pharmaceutical companies conducting drug discovery and development work.

7 investors

Using few-shot learning to design better drug candidates, faster

7 investors

Valens develops high-performance connectivity chipsets that are embedded in devices to support digital and connectivity experiences. The company positions itself as a provider of semiconductor connectivity technology.

7 investors

Verisilicon is a Chinese semiconductor IP and chip design solutions company that provides Silicon Platform as a Service (SiPaaS), offering customized chip design platforms with proprietary IP cores including GPU, NPU, VPU, DSP, ISP, and display processing IPs. The company serves chip designers, IDM manufacturers, system integrators, internet companies, and cloud service providers across consumer electronics, automotive, computing, industrial, data processing, and IoT sectors.

7 investors

Verne Robotics develops robotics technology, with a focus on multi-modal perception capabilities. The company is founded by a researcher with expertise in vision systems and robotic perception.

7 investors

CesiumAstro develops AI-enhanced, software-defined communications systems for space, air, and ground domain applications. The company provides advanced communication capabilities to mission-critical users across multiple operational environments.

7 investors

Vycarb builds an aqueous chemical reactor and real-time sensing system that convert industrial CO₂ into stable bicarbonate using water, permanently storing carbon. The technology targets emissions from hard-to-decarbonize sectors such as power, oil & gas, chemicals, biogas, cement, steel, and aluminum.

7 investors

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

7 investors

Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.

7 investors

Wild Microbes uses synthetic biology to engineer microbes sourced from diverse wild biomes into production hosts for biomanufacturing high-performance ingredients. Its product pipeline spans emulsifiers, cleansers, vitamins, supplements, and industrial chemicals for partners seeking renewable, microbe-made inputs.

7 investors

Windfall Bio develops microbial-based solutions that convert methane into valuable products for industrial and agricultural customers. The company uses naturally occurring microorganisms to enable commercial-scale methane mitigation across industries.

7 investors

Xcimer Energy develops laser-driven inertial fusion technology, aiming to turn decades of fusion research into commercial fusion power plants that provide large-scale electricity while supporting air defense and national security applications. It is a deeptech energy company building laser and pulsed-power systems for fusion power generation.

7 investors

Zap Energy develops advanced nuclear systems built on a shared platform that combines fission and fusion technologies to deliver firm, carbon-free electricity and process heat in modular, deployable formats. Its reactors target applications including AI and data center infrastructure, remote and mining sites, industrial power and heat, logistics electrification, and national security facilities.

7 investors

Zapata Quantum is a publicly traded company (OTCQB: ZPTA) that develops quantum algorithms and applies agentic AI to automate quantum resource estimation workflows. Its work targets quantum chemistry applications, including drug discovery, energy, and advanced materials development.

7 investors

Pixie Dust Technologies develops hardware products and services based on ultrasonic and sound research, including a hair care device using non-contact vibration pressure stimulation, open-ear earphones and TV speakers using gamma-wave sound, sound-absorbing materials, and indoor positioning and spatial DX platforms. Its offerings span consumer wellness devices, accessibility services for hearing and translation, and acoustic materials.

7 investors

Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.

7 investors

Miresso develops beryllium materials and supply chain solutions for fusion energy applications. The company aims to enable stable beryllium supply for commercial fusion reactor deployment.

7 investors